Neogen Chemicals Limited

BSE: 542665 NSE: NEOGEN
Neogen Chemicals Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN L24200MH1989PLC050919 Incorporated 07 March 1989 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed - NSE: NEOGEN · BSE: 542665 Public Limited Company chemicals and materials
Data last updated
Market Cap
₹6,822 Cr
NEOGEN · NSE
Share Price
₹2,261.70
-0.41% today
Revenue
₹862 Cr
FY 2025-26 · +10.9% YoY
EBITDA
₹137 Cr
Margin 15.9%
Net Profit
₹28.75 Cr
FY 2025-26 · -33.6% YoY
P/E (TTM)
183.7x
P/B 4.1x
ROE
3.6%
ROCE 6.4%
Debt / Equity
1.24
Interest cover 68.4x

About Neogen Chemicals Limited

Data last updated:

Neogen Chemicals Limited is a public limited company based in Thane, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 07 March 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24200MH1989PLC050919. Its GSTIN is 27AAACN5836E1ZJ (Maharashtra). The company holds 4 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 542665 and NSE: NEOGEN.

The company has an authorised share capital of ₹100.03 Cr and a paid-up capital of ₹30.04 Cr. It was formerly known as Neogen Chemicals Private Limited. It is led by directors including Harin Haridas Kanani (Managing Director) and Shyamsunder Radheshyam Upadhyay (Whole-Time Director).

Its last annual general meeting (AGM) was held on 21 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Office No 1002 10th Floor Dev Corpora Bldg Opp. Cadbury Co Pokhran Raod No.2 Khopat, Thane, Maharashtra, India – 400601.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹861.96 Cr, a growth of 10.9% compared to the previous year. For the same year it recorded a net profit of ₹28.75 Cr (net margin 3.3%) and EBITDA of ₹137.29 Cr (EBITDA margin 15.9%). The net worth stands at ₹816.25 Cr (up 3.4% YoY). Total assets are valued at ₹2,229.19 Cr (up 59.3% YoY).

The company has about 601 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Neogen Chemicals. As per MCA filings, the company has open charges of ₹1,836.69 Cr and satisfied charges of ₹626.4 Cr on record. Court records list 35 cases involving the company, including 16 filed by the company and 19 filed against it. The company has 36 deals on record (14 market trades, 12 secondary share transfers, 8 funding rounds), with disclosed funding of ₹599.98 Cr; the latest was in June 2026. Its 7 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Sudarshan Colorants India Limited with revenue of ₹843.83 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 643 overdue payments to 124 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neogenchem.com.

Company details

CIN L24200MH1989PLC050919
Registration Number 050919
Incorporation Date 07 March 1989
ROC Mumbai
Listing Status Listed - Listed on NSE (NEOGEN); Listed on BSE (542665)
Company Status Active
Date of Last AGM 21 August 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

Neogen Chemicals has one previous CIN (Corporate Identification Number): U24200MH1989PLC050919. The current CIN is L24200MH1989PLC050919, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24200MH1989PLC050919Current
U24200MH1989PLC050919Previous
Key People
Harin Haridas Kanani Managing Director Shyamsunder Radheshyam Upadhyay Whole-Time Director Avi Kersi Sabavala Director

Contact details

Neogen Chemicals Limited's registered office is in Thane, Maharashtra. Its website is neogenchem.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    neogenchem.com
  • Social Media
  • Registered Address
    Office No 1002 10th Floor Dev Corpora Bldg Opp. Cadbury Co Pokhran Raod No.2 Khopat, Thane, Maharashtra, India – 400601
  • Industry
    Chemicals and Materials, Specialty Chemicals

To see the full contact details of Neogen Chemicals Limited, buy the company report.

Comprehensive company report
Neogen Chemicals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Neogen Chemicals operates one associated brand: Neogen Chemicals. Each brand links to its own profile.

BrandDescriptionWebsite
Neogen Chemicals
Specialty chemicals are manufactured for diverse applications worldwide.neogenchem.com

Business activity

The main business activity of Neogen Chemicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Neogen Chemicals Limited, buy the company report.

Financials of Neogen Chemicals Limited

FY 2025-26 filings available

Neogen Chemicals Limited reported revenue of ₹861.96 Cr (up 10.9% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹862 Cr
+10.9% YoY
EBITDA
₹137 Cr
+12.3% YoY
Profit After Tax
₹28.75 Cr
-33.6% YoY
Net Worth
₹816 Cr
+3.4% YoY
Total Assets
₹2,229 Cr
+59.3% YoY
Total Debt
₹1,395 Cr
+133.8% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue862778691686487336306
Revenue growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
EBITDA13712211011286.5964.3658.06
EBITDA margin+15.9%+15.7%+15.9%+16.3%+17.8%+19.1%+19.0%
Profit before tax41.0850.1652.7771.0357.0744.2141.10
Net profit28.7543.3235.6549.9744.6331.3328.65
Net profit margin+3.3%+5.6%+5.2%+7.3%+9.2%+9.3%+9.4%
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
Balance sheet
Total assets2,2291,3991,182860676410306
Net worth816789760483439183156
Total debt1,395597409370229222137
Cash & bank4.954.9612.4920.7045.221.211.48
Net working capital732669528405299166188
Cash flow
Cash from operations(231)196(29.15)(30.35)1.4183.57(34.55)
Cash from investing(410)(317)(216)(94.46)(146)(135)(28.63)
Cash from financing64211323710018850.7362.64
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue250247220209187203201193
Revenue growth (YoY)+34.0%+21.6%+9.2%+7.9%+3.8%---
Other income4.061.012.201.981.230.641.140.84
EBITDA48.2343.9131.9029.9631.5122.3034.6434.51
EBITDA margin+19.3%+17.8%+14.5%+14.4%+16.9%+11.0%+17.2%+17.8%
Depreciation8.207.606.837.315.786.767.107.12
Interest20.8121.4721.5119.4812.6712.5013.4312.75
Profit before tax23.2815.855.765.1514.293.6815.2515.48
Tax6.174.462.071.784.031.275.244.52
Net profit17.1111.393.693.3710.262.4110.0110.96
EPS (₹)6.294.321.401.283.890.913.804.15
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue855774701686487336306
Revenue growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
EBITDA15113411611286.5964.3658.06
EBITDA margin+17.7%+17.3%+16.6%+16.3%+17.8%+19.1%+19.0%
Profit before tax63.1366.3659.4671.1157.1644.3241.22
Net profit45.8357.9341.1350.0544.7231.4428.77
Net profit margin+5.4%+7.5%+5.9%+7.3%+9.2%+9.4%+9.4%
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
Balance sheet
Total assets1,6031,2961,188861676410307
Net worth854809766483439183157
Total debt736474409370229222137
Cash & bank3.050.482.3020.7045.221.211.48
Net working capital719762639406299167189
Cash flow
Cash from operations(99.20)199(134)(30.35)1.2083.29(34.12)
Cash from investing(35.16)(188)(129)(94.46)(146)(134)(28.88)
Cash from financing137(12.14)22610018850.7362.46
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue252249216207185204200193
Revenue growth (YoY)+36.7%+22.0%+7.6%+7.0%+4.7%---
Other income7.903.874.264.373.312.652.052.24
Total expenses204203179172150176163157
EBITDA48.1645.3836.2634.9534.6827.6137.6536.49
EBITDA margin+19.1%+18.3%+16.8%+16.9%+18.8%+13.6%+18.8%+18.9%
Depreciation6.836.385.876.394.886.016.586.61
Interest23.1022.9522.8520.6014.0316.5013.0712.30
Profit before tax26.1319.9211.8012.3319.087.7520.0519.82
Tax6.695.263.033.024.852.565.644.96

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 29 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue250247220209187203201193
Revenue growth (YoY)+34.0%+21.6%+9.2%+7.9%+3.8%---
Other income4.061.012.201.981.230.641.140.84
EBITDA48.2343.9131.9029.9631.5122.3034.6434.51
EBITDA margin+19.3%+17.8%+14.5%+14.4%+16.9%+11.0%+17.2%+17.8%
Depreciation8.207.606.837.315.786.767.107.12
Interest20.8121.4721.5119.4812.6712.5013.4312.75
Profit before tax23.2815.855.765.1514.293.6815.2515.48
Tax6.174.462.071.784.031.275.244.52
Net profit17.1111.393.693.3710.262.4110.0110.96
EPS (₹)6.294.321.401.283.890.913.804.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue862778691686487336306
Revenue growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
Other income6.424.217.654.551.250.520.21
Total expenses725655581575401272248
Employee cost12475.4962.0046.8231.5020.0717.25
EBITDA13712211011286.5964.3658.06
EBITDA margin+15.9%+15.7%+15.9%+16.3%+17.8%+19.1%+19.0%
Depreciation27.5227.7922.8716.2011.696.905.24
Interest75.1148.5042.0628.9419.0813.7711.93
Profit before tax41.0850.1652.7771.0357.0744.2141.10
Tax12.3315.3317.1221.0612.4412.8812.45
Net profit28.7543.3235.6549.9744.6331.3328.65
Net profit margin+3.3%+5.6%+5.2%+7.3%+9.2%+9.3%+9.4%
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital26.3826.3826.3824.9424.9423.3323.33
Reserves & surplus790763734458414160133
Shareholders' funds (net worth)816789760483439183156
Minority interest0.000.000.000.000.000.000.00
Secured loans1,330566394362225216137
Unsecured loans65.2030.7015.397.304.025.740.00
Total debt1,395597409370229222137
Total liabilities2,2291,3991,182860676410306
Assets
Gross block568475561390313144120
Net block475404496347285127111
Capital work in progress85715610935.8410.621152.69
Investments0.450.450.4576.8181.730.750.60
Inventories568309382293195114130
Sundry debtors38020028217711078.5575.23
Cash & bank balances4.954.9612.4920.7045.221.211.48
Loans & advances43948610788.7262.3946.3724.47
Total current assets1,3931,000784580412240231
Total current liabilities66133125617411374.0243.11
Net working capital732669528405299166188
Total assets2,2291,3991,182860676410306
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash4.9612.5020.7045.221.211.482.02
Net cash from operating activities(231)196(29.15)(30.35)1.4183.57(34.55)
Net cash from investing activities(410)(317)(216)(94.46)(146)(135)(28.63)
Net cash from financing activities64211323710018850.7362.64
Net change in cash(0.03)(7.54)(8.20)(24.52)44.01(0.27)(0.54)
Closing cash4.954.9612.4920.7045.221.211.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.9%+12.6%+0.7%+40.8%+44.8%+9.9%-
EBITDA growth+12.3%+11.1%-1.4%+28.9%+34.5%+10.9%-
PBT growth-18.1%-5.0%-25.7%+24.5%+29.1%+7.6%+40.5%
Net income growth-33.6%+21.5%-28.7%+12.0%+42.5%+9.4%-
Revenue CAGR (3Y)+7.9%+16.9%+27.1%+30.9%+26.8%+27.8%+40.6%
EBITDA CAGR (3Y)+7.1%+12.2%+19.6%+24.3%+25.9%+30.4%+42.7%
Profitability & leverage
Net income margin+3.3%+4.5%+5.2%+7.3%+9.2%+9.3%+9.4%
Return on capital employed+6.4%+8.7%+9.3%+13.0%+14.0%+16.2%+21.2%
Return on net worth+3.6%+5.6%+5.7%+10.8%+14.3%+18.5%+25.3%
Debt / equity1.240.650.630.650.721.061.03
Long-term debt / equity0.660.210.220.280.390.440.29
Interest cover68.4251.3548.2530.3325.4723.9622.59
Efficiency & per share
Fixed asset turnover1.651.501.451.952.133.043.34
Inventory turnover1.962.252.052.813.163.293.44
Debtors turnover2.973.233.014.785.185.215.12
EPS (₹)10.9013.2013.5120.0417.8913.4312.28
Dividend per share (₹)2.001.002.003.002.752.252.00
Book value per share (₹)309.43299.24288.21193.47176.1278.4466.96
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue252249216207185204200193
Revenue growth (YoY)+36.7%+22.0%+7.6%+7.0%+4.7%---
Other income7.903.874.264.373.312.652.052.24
Total expenses204203179172150176163157
EBITDA48.1645.3836.2634.9534.6827.6137.6536.49
EBITDA margin+19.1%+18.3%+16.8%+16.9%+18.8%+13.6%+18.8%+18.9%
Depreciation6.836.385.876.394.886.016.586.61
Interest23.1022.9522.8520.6014.0316.5013.0712.30
Profit before tax26.1319.9211.8012.3319.087.7520.0519.82
Tax6.695.263.033.024.852.565.644.96
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue855774701686487336306
Revenue growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
Other income15.829.768.084.631.340.630.33
Total expenses704640585575401272248
Employee cost77.7258.2957.3246.8231.5020.0717.25
EBITDA15113411611286.5964.3658.06
EBITDA margin+17.7%+17.3%+16.6%+16.3%+17.8%+19.1%+19.0%
Depreciation23.5325.5922.8216.2011.696.905.24
Interest80.4251.3842.0028.9419.0813.7711.93
Profit before tax63.1366.3659.4671.1157.1644.3241.22
Tax16.1717.9518.3321.0612.4412.8812.45
Net profit45.8357.9341.1350.0544.7231.4428.77
Net profit margin+5.4%+7.5%+5.9%+7.3%+9.2%+9.4%+9.4%
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital26.3826.3826.3824.9424.9423.3323.33
Reserves & surplus827782740458414160133
Shareholders' funds (net worth)854809766483439183157
Secured loans671444394362225216137
Unsecured loans64.2630.7015.407.304.025.740.00
Total debt736474409370229222137
Total liabilities1,6031,2961,188861676410307
Assets
Gross block384299428390313144119
Net block294228361347285127111
Capital work in progress16127.5356.1035.8410.621152.69
Investments3071935.4576.5181.210.450.45
Inventories552306382293195114130
Sundry debtors35719928217711078.5575.23
Cash & bank balances3.050.482.3020.7045.221.211.48
Loans & advances36056116589.1262.9946.7825.11
Total current assets1,2711,066832580412241232
Total current liabilities55330419317411374.0243.11
Net working capital719762639406299167189
Total assets1,6031,2961,188861676410307
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.482.3038.9945.221.211.482.02
Net cash from operating activities(99.20)199(134)(30.35)1.2083.29(34.12)
Net cash from investing activities(35.16)(188)(129)(94.46)(146)(134)(28.88)
Net cash from financing activities137(12.14)22610018850.7362.46
Net change in cash2.56(1.82)(36.69)(24.52)44.01(0.27)(0.54)
Closing cash3.050.482.3020.7045.221.211.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.6%+10.3%+2.2%+40.8%+44.8%+9.9%-
EBITDA growth+13.2%+15.0%+4.1%+28.9%+34.5%+10.9%-
PBT growth-4.9%+11.6%-16.4%+24.4%+29.0%+7.5%+40.4%
Net income growth-20.9%+40.9%-17.8%+11.9%+42.2%+9.3%-
Revenue CAGR (3Y)+7.6%+16.7%+27.8%+30.9%+26.8%+27.8%+40.6%
EBITDA CAGR (3Y)+10.7%+15.5%+21.8%+24.3%+25.9%+30.4%+42.7%
Profitability & leverage
Net income margin+5.5%+6.3%+5.9%+7.3%+9.2%+9.4%+9.4%
Return on capital employed+9.9%+10.6%+9.9%+13.0%+14.0%+16.2%+21.2%
Return on net worth+5.7%+7.4%+6.6%+10.9%+14.4%+18.5%+25.3%
Debt / equity0.730.560.620.650.721.061.03
Long-term debt / equity0.210.130.220.280.390.440.29
Interest cover62.9647.5844.9830.3325.4723.9622.59
Efficiency & per share
Fixed asset turnover2.502.131.721.952.133.053.37
Inventory turnover1.992.252.082.813.163.293.44
Debtors turnover3.083.213.054.785.185.215.12
EPS (₹)17.8018.3515.5920.0717.9313.4812.33
Dividend per share (₹)2.001.002.003.002.752.252.00
Book value per share (₹)323.62306.61290.41193.51176.1578.4967.17

To see the full year-wise statements and ratios of Neogen Chemicals Limited, buy the company report.

Board of directors of Neogen Chemicals Limited

Neogen Chemicals has 8 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shyamsunder Radheshyam Upadhyay
Also directs: Neogen Ionics Limited, Neogen Morita New Materials Limited, Cadamba Solutions Private Limited
Whole-Time Director27 Jul 201511 Years 3 MonthsCurrent
Harin Haridas Kanani
Also directs: Neogen Ionics Limited, Neogen Morita New Materials Limited, Cadamba Solutions Private Limited
Managing Director15 Jul 201313 Years 3 MonthsCurrent
Avi Kersi Sabavala
Also directs: Munjal Auto Industries Limited, Indutch Composites Technology Private Limited
Director06 Oct 20188 Years 0 MonthsCurrent
Ranjan Kumar Malik
Also directs: Neogen Ionics Limited
Director06 Oct 20188 Years 0 MonthsCurrent
Anurag Surana
Also directs: Privi Speciality Chemicals Limited, Yasho Industries Limited, DCM Shriram Industries Limited and 4 more
Director15 May 20179 Years 5 MonthsCurrent
Triplicane Commandoor Narasimhan Saikrishnan
Also directs: Neogen Ionics Limited, Neogen Morita New Materials Limited, Dahej Pcpir Industries Association
Director01 Oct 20251 Years 0 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Neogen Chemicals Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Neogen Chemicals Limitedthis company₹861.96 Cr (FY 2026)₹28.75 Cr3.3%10.9%601Thane, Maharashtra, India
Sudarshan Colorants India Limited₹843.83 Cr (FY 2025)6.0%Thane, Maharashtra, India
Navin Fluorine Advanced Sciences Limited₹842.48 Cr (FY 2025)10.0%Mumbai, Maharashtra, India
Krishna Antioxidants Private Limited₹829.3 Cr (FY 2025)11.0%Mumbai, Maharashtra, India
Unitop Chemicals Private Limited₹774.29 Cr (FY 2025)18.0%Mumbai, Maharashtra, India
Gramercy Trade Industries Private Limited₹767.72 Cr (FY 2025)1324.0%Pune, Maharashtra, India
Eskay Iodine Private Limited₹741.41 Cr (FY 2025)33.0%Mumbai, Maharashtra, India
Gulbrandsen Technologies (India) Private Limited₹738.25 Cr (FY 2024)5.0%Vadodara, Gujarat, India

To see the full peer comparison of Neogen Chemicals Limited, buy the company report.

Auditor

Neogen Chemicals Limited is audited by JMT & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
JMT & ASSOCIATESFY 2023104167W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 53.00%, foreign institutional investors hold 4.10%, domestic institutional investors hold 19.60% and retail and other public shareholders hold 23.30%.

Promoters: 53.00%DII (Domestic Institutional): 19.60%FII (Foreign Institutional): 4.10%Retail & Others: 23.30%
Sep 2026
QUARTER
53.00% Promoters
19.60% DII (Domestic Institutional)
4.10% FII (Foreign Institutional)
23.30% Retail & Others
Promoter holding - history
Now 53.00% · Sep 2026High 53.00% · Sep 2026Low 51.20% · Dec 2025
50%51%52%53%54%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 51.20%Mar 2026: 51.20%Jun 2026: 51.20%Sep 2026: 53.00%51.20%53.00%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters53.00%51.20%51.20%51.20%
Public47.00%48.80%48.80%48.80%

Charges & borrowings

Open charges
₹1,836.69 Cr
Satisfied charges
₹626.4 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹1,381.69 Cr
Others₹310.00 Cr
Hdfc Bank Limited₹95.00 Cr
Axis Bank Limited₹50.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Mar 2026101270600Others₹20 CrOpen
06 Aug 2025101160884Others₹200 CrOpen
28 Jun 2025101116161Others₹65 CrOpen
18 Oct 2024100996488Sbicap Trustee Company Limited₹487.69 CrOpen
20 Jul 2024100954537Sbicap Trustee Company Limited₹894 CrOpen

To see the full charge records of Neogen Chemicals Limited, buy the company report.

Total charge records: 27 View all charges

Deals & funding

Neogen Chemicals Limited has 36 deals on record (14 market trades, 12 secondary share transfers, 8 funding rounds), with disclosed funding of ₹599.98 Cr; the latest was in June 2026.

Total deals
36
Market trades
14
Secondary share transfers
12
Funding rounds
8
IPO
1
Disclosed funding
₹599.98 Cr

Deals on record (5 of 36)

WhenDealAmountParties
Dec 2025Market trade₹17.11 CrBuyer: Junomoneta Finsol Private Limited
Seller: Junomoneta Finsol Private Limited
Dec 2025Market trade₹198.85 CrBuyer: Alphagrep Securities Private Limited , Qe Securities LLP , Junomoneta Finsol Private Limited
Seller: Alphagrep Securities Private Limited , Qe Securities LLP , Junomoneta Finsol Private Limited
Sep 2024Market trade₹38.97 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Jun 2024Market trade₹298.47 CrBuyer: Custody Bank Of Japan Ltd Re Rb Amundi India Small Cap Equity Mother Fund, India Acorn Icav, Setu Securities Private Limited
Seller: Setu Securities Private Limited , Mansi Share And Stock Advisors Pvt Ltd, an individual
Apr 2023Market trade₹24.66 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP

To see the full deal history of Neogen Chemicals Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Neogen Chemicals Limited was last rated by Crisil on 31 Oct 2019.

Rating agencyRated onRating
Crisil31 Oct 2019

To see the full credit ratings and regulatory alerts of Neogen Chemicals Limited, buy the company report.

MSME payment delays

Neogen Chemicals Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 643 overdue payments to 124 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 124)

SupplierAmount dueDue sinceReported on
Ideal Lighting Systems Pvt Ltd
Tulip Chemicals Private Limited
an individual supplier
an individual supplier
Gracious Exports

To see the full MSME payment records of Neogen Chemicals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Neogen Chemicals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Neogen Ionics LimitedU20119MH2023PLC399825

To see the full group structure of Neogen Chemicals Limited, buy the company report.

Employees & EPFO

Neogen Chemicals Limited has a workforce of 601 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.

Employee count
601
Active EPFO establishments
2
Employee growth
13.83%

GST

Neogen Chemicals has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACN5836E1ZJMaharashtraActive01 Jul 2017
24AAACN5836E2ZOGujaratActive01 Jul 2017
24AAACN5836E3ZNGujaratActive11 Jan 2019

To see the full GST registrations and return filing status of Neogen Chemicals Limited, buy the company report.

Recent activity

Neogen Chemicals Limited has 24 board changes on record since 1989: 16 appointments and 8 cessations. The latest: Triplicane Commandoor Narasimhan Saikrishnan was appointed as Director on 01 Oct 2025.

AGM
Neogen Chemicals Limited last Annual general meeting of members was held on 21 Aug 2026 as per latest MCA records.
Charges
A charge registered on 22 Mar 2021 via Charge ID 100433809 with Hdfc Bank Limited was fully satisfied on 07 May 2026.
Filing
Neogen Chemicals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101270600 was registered on 28 Mar 2026.
Charges
A charge registered on 14 Oct 1998 via Charge ID 90142236 with State Bank Of India was fully satisfied on 10 Mar 2026.
Appointed
Triplicane Commandoor Narasimhan Saikrishnan was appointed as Director.
Ceased
Haridas Thakarshi Kanani ceased to be Managing Director.
Charges
A charge registered on 07 Feb 2024 via Charge ID 100871310 with Axis Bank Limited was fully satisfied on 17 Sep 2025.
Charges
A charge with Others amounted to Rs. 200.00 Cr with Charge ID 101160884 was registered on 06 Aug 2025.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 487.69 Cr registered on 18 Oct 2024 with Charge ID 100996488 was modified on 17 Jul 2025.
Charges
A charge registered on 02 Jun 2022 via Charge ID 100583256 with Others was fully satisfied on 11 Jul 2025.
Charges
A charge with Others amounted to Rs. 65.00 Cr with Charge ID 101116161 was registered on 28 Jun 2025.

79 earlier events are in the company report.

News

Neogen Chemicals: Morita Investment To Invest ₹76.80 Crore In Neogen Morita New Materials, Acquire 9.09% Stake
28 Sep 2026 · Exchange Update
Government Plans New Program to Enhance Lithium and Nickel Processing, Reports Mines Secretary Keshav Chandra.
23 Sep 2026 · Exchange Update
Neogen Chemicals: Raises ₹600 Crore Through QIP, Shares Allotted At ₹2,255 Each With 6.5X Oversubscription
21 Sep 2026 · Exchange Update

Frequently asked questions

Neogen Chemicals is an active public limited company based in Thane, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 07 March 1989 (37+ years old) and is registered under CIN L24200MH1989PLC050919. Listed on BSE: 542665 and NSE: NEOGEN.

Neogen Chemicals reported revenue of ₹861.96 Cr for FY 2025-26 (up 10.9% YoY) based on consolidated financials.

Neogen Chemicals has 8 current directors:

The latest financial statements of Neogen Chemicals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 21 August 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Neogen Chemicals is 27AAACN5836E1ZJ, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACN5836E2ZO (Gujarat), 24AAACN5836E3ZN (Gujarat).

The CIN (Corporate Identification Number) of Neogen Chemicals is L24200MH1989PLC050919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Neogen Chemicals is a listed company as per MCA records. Its shares are listed on both BSE (code: 542665) and NSE (symbol: NEOGEN).

Neogen Chemicals has 35 court cases on record: 16 filed by the company and 19 filed against it. Most are in the high courts.

Neogen Chemicals was incorporated on 07 March 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.

Neogen Chemicals has 36 deals on record (14 market trades, 12 secondary share transfers, 8 funding rounds), with disclosed funding of ₹599.98 Cr; the latest was in June 2026.

The peers of Neogen Chemicals by revenue are Sudarshan Colorants India Limited, Navin Fluorine Advanced Sciences Limited, Krishna Antioxidants Private Limited, Unitop Chemicals Private Limited, Gramercy Trade Industries Private Limited and 2 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Triplicane Commandoor Narasimhan Saikrishnan was appointed as Director on 01 Oct 2025. Haridas Thakarshi Kanani ceased to be Managing Director on 30 Sep 2025. Ullal Ravindra Bhat ceased to be Director on 28 Oct 2024. Neogen Chemicals has 24 board changes on record in total.